FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Olmesartan Medoxomil and Hydrochlorothiazide Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Mylan Pharmaceuticals Inc. (New 05/02/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
20mg/12.5mg, 30 count bottle (NDC 0378-1413-93) 05/02/2019
20mg/12.5mg, 90 count bottle (NDC 0378-1413-77) 05/02/2019
40mg/12.5mg, 30 count bottle (NDC 0378-1422-93) 05/02/2019
40mg/12.5mg, 90 count bottle (NDC 0378-1422-77) 05/02/2019
40mg/25mg, 30 count bottle (NDC 0378-1425-93) 05/02/2019
40mg/25mg, 90 count bottle (NDC 0378-1425-77) 05/02/2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English